PropertyValue
?:abstract
  • Widespread testing is required to limit the current public health crisis caused by the COVID-19 pandemic. Multiple tests protocols have been authorized by the food and drugs administration (FDA) under an emergency use authorization (EUA). The majority of these protocols are based on the gold-standard RT-qPCR test pioneered by the U.S. Centers for Disease Control and Prevention (CDC). However, there is still a widespread lack of testing in the US and many of the clinical diagnostics protocols require extensive human labor and materials that could face supply shortages and present biosafety concerns. Given the need to develop alternative reagents and approaches to provide nucleic-acid testing in the face of heightened demand and potential shortages, we have developed a simplified SARS-CoV-2 testing protocol adapted for its use in research laboratories with minimal molecular biology equipment and expertise. The protocol utilizes TRIzol to purify the viral RNA from different types of clinical specimens, requires minimal BSL-1 precautions and, given its high sensitivity, can be easily adapted to pooling samples strategies.
is ?:annotates of
?:creator
?:doi
  • 10.1371/journal.pone.0244271
?:doi
?:journal
  • PLoS_One
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/dcb588b9de135359be96cb069647372bf1ea9926.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7748277.xml.json
?:pmcid
?:pmid
?:pmid
  • 33338082.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • A simplified SARS-CoV-2 detection protocol for research laboratories
?:type
?:year
  • 2020-12-18

Metadata

Anon_0  
expand all